Haploidentical stem cell transplantation with CD3⁺-/CD19⁺- depleted peripheral stem cells for patients with advanced stage sickle cell disease and no alternative donor: results of a pilot study

Bone Marrow Transplant. 2017 Jun;52(6):938-940. doi: 10.1038/bmt.2017.49. Epub 2017 Apr 24.

Authors

J Foell¹, B Pfirstinger¹, K Rehe¹, D Wolff², E Holler², S Corbacioglu¹

Affiliations

¹ Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Regensburg, Germany.
² Department of Internal Medicine III, Hematology and Oncology, University Hospital of Regensburg, Regensburg, Germany.

PMID: 28436975
DOI: 10.1038/bmt.2017.49

No abstract available

Publication types

Clinical Trial

MeSH terms

Adolescent
Adult
Allografts
Anemia, Sickle Cell / therapy*
Antigens, CD19*
CD3 Complex*
Child
Child, Preschool
Female
Humans
Lymphocyte Depletion*
Male
Peripheral Blood Stem Cell Transplantation / methods*
Pilot Projects
Unrelated Donors*

Substances

Antigens, CD19
CD19 molecule, human
CD3 Complex